» Articles » PMID: 22118570

Resveratrol Mitigates Lipopolysaccharide- and Aβ-mediated Microglial Inflammation by Inhibiting the TLR4/NF-κB/STAT Signaling Cascade

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2011 Nov 29
PMID 22118570
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of microglia, the resident macrophages of the brain, around the amyloid plaques is a key hallmark of Alzheimer's disease (AD). Recent evidence in mouse models indicates that microglia are required for the neurodegenerative process of AD. Amyloid-β (Aβ) peptides, the core components of the amyloid plaques, can trigger microglial activation by interacting with several Toll-like receptors (TLRs), including TLR4. In this study, we show that resveratrol, a natural polyphenol associated with anti-inflammatory effects and currently in clinical trials for AD, prevented the activation of murine RAW 264.7 macrophages and microglial BV-2 cells treated with the TLR4 ligand, lipopolysaccharide (LPS). Resveratrol preferentially inhibited nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) activation upon LPS stimulation by interfering with IKK and IκB phosphorylation, an effect that potently reduced the transcriptional stimulation of several NF-κB target genes, including tumor necrosis factor-α and interleukin-6. Consequently, downstream phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3 upon LPS stimulation was also inhibited by resveratrol. We found that resveratrol acted upstream in the activation cascade by interfering with TLR4 oligomerization upon receptor stimulation. Resveratrol treatment also prevented the pro-inflammatory effect of fibrillar Aβ on macrophages by potently inhibiting the effect of Aβ on IκB phosphorylation, activation of STAT1 and STAT3, and on tumor necrosis factor-α and interleukin-6 secretion. Importantly, orally administered resveratrol in a mouse model of cerebral amyloid deposition lowered microglial activation associated with cortical amyloid plaque formation. Together this work provides strong evidence that resveratrol has in vitro and in vivo anti-inflammatory effects against Aβ-triggered microglial activation. Further studies in cell culture systems showed that resveratrol acted via a mechanism involving the TLR4/NF-κB/STAT signaling cascade.

Citing Articles

Promising Natural Remedies for Alzheimer's Disease Therapy.

Thawabteh A, Ghanem A, AbuMadi S, Thaher D, Jaghama W, Karaman D Molecules. 2025; 30(4).

PMID: 40005231 PMC: 11858286. DOI: 10.3390/molecules30040922.


The Potential Effects of Red Wine and Its Components on Neurocognitive Disorders: A Narrative Review.

Boccardi V, Tagliafico L, Persia A, Page E, Ottaviani S, Cremonini A Nutrients. 2024; 16(20).

PMID: 39458427 PMC: 11510231. DOI: 10.3390/nu16203431.


Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer's Disease: A Review.

Doke R, Lamkhade G, Vinchurkar K, Singh S ACS Pharmacol Transl Sci. 2024; 7(10):2987-3003.

PMID: 39416969 PMC: 11475310. DOI: 10.1021/acsptsci.4c00457.


Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies.

Sun Z, Zhang X, So K, Jiang W, Chiu K Biomolecules. 2024; 14(7).

PMID: 39062547 PMC: 11274940. DOI: 10.3390/biom14070833.


Sebacic acid, a royal jelly-containing fatty acid, decreases LPS-induced IL-6 mRNA expression in differentiated human THP-1 macrophage-like cells.

Ogawa E, Suzuki N, Kamiya T, Hara H J Clin Biochem Nutr. 2024; 74(3):192-198.

PMID: 38799138 PMC: 11111463. DOI: 10.3164/jcbn.23-16.


References
1.
Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

2.
Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W . LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain. 2005; 128(Pt 8):1778-89. DOI: 10.1093/brain/awh531. View

3.
Landreth G, Reed-Geaghan E . Toll-like receptors in Alzheimer's disease. Curr Top Microbiol Immunol. 2009; 336:137-53. PMC: 3032986. DOI: 10.1007/978-3-642-00549-7_8. View

4.
Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho E . Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem. 2005; 281(6):3651-9. DOI: 10.1074/jbc.M508125200. View

5.
Wang C, Deng L, Hong M, Akkaraju G, Inoue J, Chen Z . TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001; 412(6844):346-51. DOI: 10.1038/35085597. View